Biotech is where science and technology meet to create innovative and impactful solutions such as diagnostics and drug development to deliver personalized patient care for life-threatening illnesses. Additionally, with breakthroughs in gene editing techniques clinical and molecular data, startups are also revolutionizing agriculture, biofuels, and environmental conservation.
As biotechnology becomes more advanced, the capabilities of this sector continue to grow and expand. These top biotech startups are pushing the limits of the industry to create life-changing treatments, devices, and more.
Best Biotech Startups to Watch
Biotechnology companies utilize the power of tech to develop innovative solutions in various fields, including healthcare, agriculture, and environmental conservation. These are the best biotech startups at the forefront of scientific innovation; their groundbreaking work holds the potential to revolutionize industries and improve lives worldwide.
Disclaimer: With so many new biotech startups launching and growing worldwide, we aren’t able to cover them all. Furthermore, the startups that are listed below are not officially ranked and are listed in no particular order.
1. Detect
- Location: Guilford, Connecticut
- Founders: Jonathan Rothberg
- Founded In: 2017
- Funding: Series C, ~$110 Million
- Investors Include: US Department of Health and Human Services, Expa, Human Capital
Detect is a technology company that utilizes the power of artificial intelligence to discover impactful, innovative biotechnology tools such as rapid PCR testing for COVID-19 as well as other industry-shifting, accessible diagnostic tools.
2. Monte Rosa Therapeutics
- Location: Boston, Massachusetts
- Founders: Ian Collins, Raj Chopra
- Founded In: 2018
- Funding: Post-IPO Equity, ~$417 Million
- Investors Include: Avoro Capital Advisors, Amzak Health Investors, Cormorant Asset Management
Monte Rosa Therapeutics provides innovative cancer therapeutics that modulate protein degradation pathways by targeting disease-creating proteins to create a more effective treatment option.
3. Colossal
- Location: Dallas, Texas
- Founders: Ben Lamm, Dr. George Church
- Founded In: 2021
- Funding: Series C, $435 Million
- Investors Include: Draper Associates, Animoca Brands, Boost VC
Colossal is a bioscience startup pioneering innovative techniques in genetic engineering and conservation biology. The company aims to restore extinct species like the woolly mammoth and the Tasmanian tiger to their natural habitats, contributing to biodiversity and combating climate change.
4. Recursion
- Location: Salt Lake City, Utah
- Founders: Blake Borgeson, Chris Gibson, Dean Li
- Founded In: 2013
- Funding: Post-IPO Equity, $665.4 Million
- Investors Include: Leaps by Bayer, Advantage Capital, Two Sigma Ventures
Recursion is a clinical-stage biotech and drug-development company that utilizes the capabilities of machine-learning technology to offer an innovative drug-discovery platform and pipeline.
5. ElevateBio
- Location: Waltham, Massachusetts
- Founders: David Hallal, Mitchell Finer, Vikas Sinha
- Founded In: 2017
- Funding: Series D, $1.2 Billion
- Investors Include: Emerson Collective, EDBI, Surveyor Capital
ElevateBio is a portfolio of impactful, inventive biotechnology companies specializing in gene and cell therapies that are utilized to develop new medicines and treatments.
6. AccessDx Lab
- Location: Houston, Texas
- Founders: Michael Stewart
- Founded In: 2016
- Funding: Undisclosed
- Investors Include: 2bPrecise
AccessDx Lab is one of the trusted leaders in COVID-19 testing. This, in combination with their various other infectious disease testing options, is essential for providing care teams with more impactful and efficient diagnostic tools.
7. Color
- Location: Burlingame, California
- Founders: Nish Bhat, Othman Laraki, Sanem Fabri, Taylor Sittler
- Founded In: 2013
- Funding: Series E, $482 Million
- Investors Include: T. Rowe Price, Kindred Ventures, General Catalyst
Color is a healthcare platform and operating system that aims to make large-scale health initiatives easier to scale and implement through software and infrastructure options that work for companies, public health agencies, and more.
8. Benchling
- Location: San Francisco, California
- Founders: Ashutosh Singhal, Cory Li, Sajith Wickramasekara
- Founded In: 2012
- Funding: Series F, $411.9 Million
- Investors Include: Altimeter Capital, Franklin Templeton Investments
Benchling is a biotech company made for biotech companies. Its cloud-software platform is created for the use of researchers and research and development organizations.
9. Absci
- Location: Vancouver, Washington
- Founders: Sean McClain
- Founded In: 2011
- Funding: Venture, $237.9 Million
- Investors Include: Redmile Group, Casdin Capital, Merck Global Health Innovation Fund
Absci incorporates artificial intelligence with synthetic biotechnology to discover and develop therapies through proteins.
10. Passage Bio
- Location: Philadelphia, Pennsylvania
- Founders: James Wilson
- Founded In: 2018
- Funding: Post-IPO Equity, $379.5 Million
- Investors Include: Len Blavatnik, Highline Capital Management, Lilly Asia Ventures
Passage Bio leverages the insight and capabilities of gene therapy to develop new and powerful medications. Through its partnership with Pennsylvania’s Gene Therapy Program (GTP), this company is able to research and develop life-changing medications and treatments.
11. Inflammatix
- Location: Burlingame, California
- Founders: Jonathan Romanowsky, Purvesh Khatri, Tim Sweeney
- Founded In: 2016
- Funding: Grant, $137.8 Million
- Investors Include: National Institutes of Health, D1 Capital Partners, DARPA
Inflammatix is a biotechnology company that has developed tech to gauge patients’ immune response to infections to inform better diagnostic and treatment options safely and easily.
12. TMRW Life Sciences
- Location: New York, New York
- Founders: Alan Murray, Jeffrey Port, Joshua Abram
- Founded In: 2018
- Funding: Angel, $153.5 Million
- Investors Include: Presight Capital, 5AM Ventures, Casdin Capital
TMRW Life Sciences is a startup pioneering the world’s first and only automated platform for the care and management of frozen embryos and eggs to be used in IVF. By using their technology and IVF management solutions, the risk of misidentifying or losing embryos or eggs in IVF is reduced significantly.
13. Maze Therapeutics
- Location: South San Francisco, California
- Founders: Charles Homcy
- Founded In: 2018
- Funding: Post-IPO Equity, $496 Million
- Investors Include: Matrix Capital Management, NS Investment, Woodline Partners
Maze Therapeutics is a biotechnology company that’s working on translating genetic insights into various therapeutic innovations and treating disease by harnessing the ultimate power of human genetics. The human genome can be imagined as a complex maze, and by navigating this maze, it is possible to create precision medicines that help patients and effectively fight disease.
14. Cellarity
- Location: Somerville, Massachusetts
- Founders: Avak Kahvejian, Jim Collins, Nick Plugis, Noubar Afeyan
- Founded In: 2017
- Funding: Series C, $274 Million
- Investors Include: Flagship Pioneering, BlackRock, The Baupost Group
Cellarity is an innovative startup in the biotech space that’s working on pioneering new therapeutics across multiple different types of diseases by understanding, targeting, and then changing behaviors of key cells. They are combining high-resolution cell data with machine learning algorithms to develop new medicines that are built entirely from a cell-centric model.
15. Bionaut Labs
- Location: Los Angeles, California
- Founders: Aviad Maizels, Michael Shpigelmacher
- Founded In: 2016
- Funding: Series B, $63.2 Million
- Investors Include: Khosla Ventures, Bioverge, Sixty Degree Capital
Bionaut Labs is reimagining therapeutics and revolutionizing treatments related to central nervous system (CNS) disorders. The unique aspect of their approach is the use of remote-controlled micro-robots that they call “Bionauts,” which, in time, will be able to help patients who are suffering from brain diseases and don’t have very many treatment options remaining.
16. Kriya Therapeutics
- Location: Palo Alto, California
- Founders: Fraser Wright, Roger Jeffs, Shankar Ramaswamy
- Founded In: 2019
- Funding: Series C, $600.5 Million
- Investors Include: CAM Capital, Alumni Ventures, Bluebird Ventures
Kriya Therapeutics is a biotechnology startup working to unleash the full power of gene therapy and redefine how they are designed, developed, and manufactured today. Their goal is to reduce production and development costs and improve the speed of marketing gene-helpful therapies, expanding their range to various diseases.
17. Orna Therapeutics
- Location: Cambridge, Massachusetts
- Founders: Alex Wesselhoeft, Daniel Anderson, Raffaella Squilloni
- Founded In: 2019
- Funding: Series B, $321 Million
- Investors Include: MPM Capital, Merck, F2 Ventures, Taiho Ventures
Orna Therapeutics is developing an entirely new class of RNA medicines called “oRNA” circular RNAs. Their new methodology is positioned to change the way we currently treat disease and works by combining innovative delivery techniques with “oRNA” circular RNAs. The treatments afforded by this technology could potentially impact regenerative medicine, cancer, infectious diseases, autoimmunity, and protein replacement.
18. 10x Genomics
- Location: Pleasanton, California
- Founders: Ben Hindson, Serge Saxonov
- Founded In: 2012
- Funding: Series D, $242.6 Million
- Investors Include: Paladin Capital Group, Meritech Capital Partners, Fidelity
10x Genomics is a startup with the ambitious goal of advancing human health through the mastery of biology. They aim to accelerate their progress through research across life sciences, in situ products, and single cells.
19. Generate:Biomedicines
- Location: Somerville, Massachusetts
- Founders: Noubar Afeyan, Avak Kahvejian
- Founded In: 2018
- Funding: Series C, $700 Million
- Investors Include: Flagship Pioneering, Amgen
Generate:Biomedicines is taking a revolutionary approach to drug development by using generative AI to create entirely new protein therapeutics from scratch. Their AI platform designs proteins that are optimized for function, speed, and efficacy, opening up treatment possibilities for a wide range of diseases.
20. Aro Biotherapeutics
- Location: Philadelphia, Pennsylvania
- Founders: Susan Dillon, Karyn O'Neil
- Founded In: 2018
- Funding: Series B, $177 Million
- Investors Include: Johnson & Johnson Innovation, Northpond Ventures, Cowen Healthcare Investments
Aro Biotherapeutics is developing innovative RNA-targeted therapies through their proprietary Centyrin platform. The company focuses on delivering precision medicine for genetically defined diseases by improving how oligonucleotides are delivered to specific tissues in the body.
21. Orbital Therapeutics
- Location: Cambridge, Massachusetts
- Founders: Giuseppe Ciaramella and others
- Founded In: September 2022
- Funding: Series A, $270 Million
- Investors Include: ARCH Venture Partners, a16z Bio + Health, Newpath Partners
Orbital Therapeutics is pushing the boundaries of RNA-based medicine by developing next-generation therapeutics for vaccines, gene editing, and protein replacement. Their innovative platform creates programmable RNA treatments that surpass traditional mRNA capabilities, with the goal of achieving more durable and customizable therapeutic delivery.
Final Thoughts
Biotech startups are at the forefront of drug development and life sciences research. Combining the power of technologies such as artificial intelligence with things like induced pluripotent stem cells and gene therapies to change the world. Or they can be a technology company creating an operating system or making data accessible for other innovative biotech companies.
Whatever sector they are innovative in, these biotech startups are changing the way patients are treated for illnesses and transforming the industry as a whole.
FAQs
1. What are biotech startups?
Biotech startups are new companies that are working to solve complicated human problems through the use of biology and the development of new technologies. As technology continues to grow and advance, the advancements provided for biotech startups will continue to multiply.
2. Are biotech startups successful?
While there are many different types of factors that play into whether or not biotech startups are inherently successful, there are a significant number of successful startup companies in this space.
3. How many biotech startups fail?
Similar to the failure rates of standard businesses, approximately every 9 out of 10 biotech startups fail. These failures can be attributed to everything from lack of capital, a change in market conditions, flawed science, or leaders who lack experience.
4. How do I start my own biotech company?
If you’d like to start your own biotech company, you’ll first have to honestly acknowledge what level your current entrepreneurial skills are at, develop your startup idea, and create a startup roadmap. Once those steps are complete, you can begin looking for individuals who can complement your team, seek startup funding, and establish your brand through promotions and marketing.
